Sanara MedTech Inc.
SMTI
$16.96
-$1.05-5.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.55M | 26.33M | 25.83M | 23.43M | 26.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.55M | 26.33M | 25.83M | 23.43M | 26.31M |
| Cost of Revenue | 1.87M | 1.87M | 1.94M | 1.84M | 2.25M |
| Gross Profit | 25.67M | 24.46M | 23.89M | 21.60M | 24.06M |
| SG&A Expenses | 20.08M | 19.88M | 21.55M | 21.44M | 20.22M |
| Depreciation & Amortization | 668.40K | 610.90K | 1.11M | 1.12M | 185.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.65M | 23.39M | 25.86M | 25.51M | 23.54M |
| Operating Income | 2.89M | 2.94M | -31.30K | -2.08M | 2.77M |
| Income Before Tax | -1.11M | 834.50K | -2.02M | -3.53M | 934.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.11M | 834.50K | -2.02M | -3.53M | 934.70K |
| Earnings from Discontinued Operations | -502.80K | -31.25M | -- | -- | -2.47M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 200.00 | 1.00K | 4.00K | 200.00 | 0.00 |
| Net Income | -1.61M | -30.41M | -2.01M | -3.53M | -1.54M |
| EBIT | 2.89M | 2.94M | -31.30K | -2.08M | 2.77M |
| EBITDA | 3.56M | 3.61M | 1.08M | -955.60K | 2.95M |
| EPS Basic | -0.19 | -3.52 | -0.23 | -0.41 | -0.18 |
| Normalized Basic EPS | 0.05 | 0.06 | -0.15 | -0.26 | 0.11 |
| EPS Diluted | -0.19 | -3.40 | -0.23 | -0.41 | -0.18 |
| Normalized Diluted EPS | 0.05 | 0.06 | -0.15 | -0.26 | 0.11 |
| Average Basic Shares Outstanding | 8.47M | 8.65M | 8.61M | 8.57M | 8.53M |
| Average Diluted Shares Outstanding | 8.47M | 8.94M | 8.61M | 8.57M | 8.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |